C07K 5/06078
And aromatic or cycloaliphatic
Official title: {and aromatic or cycloaliphatic}
C07K5/06078 (And aromatic or cycloaliphatic) appears on 1,034 US grants and 793 published applications in this corpus.
Search patents in C07K- Granted patents
- 1,034
- Published applications
- 793
- Assignees
- 571
- Inventors
- 2,748
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 5 | 0 |
| 1978 | 10 | 0 |
| 1979 | 6 | 0 |
| 1980 | 5 | 0 |
| 1981 | 7 | 0 |
| 1982 | 6 | 0 |
| 1983 | 6 | 0 |
| 1984 | 12 | 0 |
| 1985 | 21 | 0 |
| 1986 | 9 | 0 |
| 1987 | 18 | 0 |
| 1988 | 21 | 0 |
| 1989 | 24 | 0 |
| 1990 | 17 | 0 |
| 1991 | 13 | 0 |
| 1992 | 12 | 0 |
| 1993 | 35 | 0 |
| 1994 | 17 | 0 |
| 1995 | 20 | 0 |
| 1996 | 27 | 0 |
| 1997 | 45 | 0 |
| 1998 | 46 | 0 |
| 1999 | 40 | 0 |
| 2000 | 27 | 0 |
| 2001 | 26 | 4 |
| 2002 | 37 | 26 |
| 2003 | 25 | 29 |
| 2004 | 16 | 32 |
| 2005 | 16 | 45 |
| 2006 | 23 | 36 |
| 2007 | 19 | 33 |
| 2008 | 20 | 20 |
| 2009 | 23 | 31 |
| 2010 | 18 | 40 |
| 2011 | 15 | 30 |
| 2012 | 15 | 29 |
| 2013 | 26 | 34 |
| 2014 | 30 | 46 |
| 2015 | 36 | 45 |
| 2016 | 35 | 45 |
| 2017 | 36 | 40 |
| 2018 | 25 | 37 |
| 2019 | 26 | 22 |
| 2020 | 27 | 21 |
| 2021 | 20 | 36 |
| 2022 | 13 | 27 |
| 2023 | 13 | 23 |
| 2024 | 14 | 29 |
| 2025 | 20 | 21 |
| 2026 | 8 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Tautomeric ligand enables biomimetic C—H hydroxylation with molecular oxygen22 Sep 2026US 12,741,937 B2The Scripps Research Institute
- Alpha-carbonyl alkenyl ester preparation method therefor and application thereof15 Sep 2026US 12,735,449 B2Jiangxi Normal University
- Small molecule inhibitors of SARS-CoV-2 viral replication and uses thereof25 Aug 2026US 12,715,896 B2Arizona Board of Regents on Behalf of the University of Arizona
- Oligopeptide linker intermediate and preparation method thereof10 Mar 2026US 12,570,692 B2Mabplex International Co., Ltd.
- IBAT inhibitors for the treatment of liver diseases10 Feb 2026US 12,545,705 B2Albireo AB
- Novel hemiasterlin derivative and use thereof10 Sep 2026US 2026/0263616 A1Pinotbio, Inc.
- Psma-targeted radiopharmaceuticals and dna damage response inhibitor combination therapy20 Aug 2026US 2026/0241048 A1Fusion Pharmaceuticals Inc.
- Cytotoxic epoxyketone compounds, precursors, compositions, and methods of use13 Aug 2026US 2026/0234116 A1
- Peptide pharmaceuticals13 Aug 2026US 2026/0234186 A1Mederis Diabetes LLC
- Flavor-enhancing composition, manufacturing method therefor, and method for enhancing flavor of food product6 Aug 2026US 2026/0223904 A1House Foods Corporation
Most cited
By later US patents
- Lysosomal enzyme-cleavable antitumor drug conjugates653US 6,214,345 B1Bristol-Myers Squibb Company · 2001
- Aminoacid derivatives and their therapeutic applications196US 4,513,009 ASociete Civile Bioprojet · 1985
- Hypotensive peptides and their use161US 4,548,926 ASankyo Company, Limited · 1985
- Intermediates in polypeptide synthesis157US 4,599,198 APfizer Inc. · 1986
- Hydroxy substituted peptide compounds142US 4,514,391 AE. R. Squibb & Sons, Inc. · 1985